Table 3.
Frequency of monitoring based on CKD stage.
| CKD Stage | Frequency of Lab Monitoring based on CKD stage | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CKD Progression | Blood Pressure | Growth Monitoring | Anemia | CKD-MBD | ||||||||
| CysC, SCr | Albuminuria | No HTN | HTN | Infants | Children | No anemia | Anemia | Ca, Phos | PTH | Vitamin 25(OH)D | AlkPhos | |
| 1 | 12mo | 6*-12mo | In-office (12mo) | In-office (every visit) ABPM (12mo) Home BPs |
Weight, Linear, HC (12mo) | Weight, Linear, +/- HC (12mo) | 12mo | 6mo | 12mo | 12mo | 12mo | – |
| 2 | 12mo | 6*-12mo | In-office (3-6mo) ABPM (12mo) |
Linear (3mo) Weight (6mo) HC (6mo) Dietitian |
Linear (12mo) Weight (6mo) Dietitian |
12mo | 6mo | 12mo | 12mo | 12mo | – | |
| 3a | 12mo | 4*-12mo | 12mo | 3mo | 6-12mo | Baseline and based on CKD progression | Baseline and 3-6mo based on level and supplements | – | ||||
| 3b | 6mo | 4*-6mo | 12mo | 3mo | 6-12mo | – | ||||||
| 4 | 4mo | 1*-4mo | 6mo | 3mo | 3-6mo | 6-12mo | – | |||||
| 5 | 1-3mo | 1*-3m | 3mo | 1mo | 1-3mo | 3-6mo | 12mo dependent on PTH | |||||
Asterix (*) indicates more frequent monitoring if the patient has significant albuminuria (A2 or A3).